Effect of Ampicillin on the kinetics of colonization of Streptococcus pneumoniae and Lactobacillus fermentum in the respiratory tract of mice
© de Gutiérrez et al; licensee BioMed Central Ltd. 2004
Received: 15 June 2004
Accepted: 27 October 2004
Published: 27 October 2004
Ampicillin was selected to further study the effect of this antibiotic on the colonization capability of S. pneumoniae and L. fermentum intranasally inoculated in a mice experimental model. The sensitivity of S. pneumoniae and L. fermentum to antibiotics was evaluated by different "in vitro" techniques. The results showed that both microorganisms have a typical pattern of sensitivity to antibiotics in these assays. The "in vivo" experiments showed that the treatment with Ampicillin increased the number of lactobacilli and neumococci in the groups of mice treated only with one of the microorganisms. In those mice treated with Lactobacillus, challenged later with neumococci and treated with Ampicillin, the pathogen in lung decreased on the 4th day, disappearing completely after on. The histological studies showed that the antibiotic treatment decreased the inflammatory response produced by the pathogen at the lung and trachea levels.
Respiratory tract infections are commonly caused by Streptococcus pneumoniae. Extensive antibiotic use for these infections as well as misuse for viral respiratory infections has led to increased penicillin resistance amongst the streptococci [1–6]. Even though there is a very broad description of the pattern of sensibility to antibiotics of this pathogen and other potentially pathogenic microorganisms, there are a small number of publications referred to the lactobacilli sensitivity to these types of compounds [7–10]. The antibiotic treatment modifies the stability of the normal or indigenous microbiota, producing the dominance of certain microorganisms able sometimes to produce a secondary infection . There are a lot of approaches trying to restore the normal microbiota, or to avoid modifications of the different ecosystems to prevent infections, both for human and animal application. One of the main research areas related to the restoration of the indigenous flora is the application of probiotic microorganisms [12–14].
Lactic Acid Bacteria (LAB) has been widely used to restore the ecologic equilibrium of different areas [12–14], mainly for the gastrointestinal tract. In the last decade, there is a lot of other research areas referred to the potential application of probiotics in the respiratory tract mainly as vaccine vectors [15–17]. They could be applied for the protection against pathogenic microorganisms as S. pneumoniae which is a frequent nasopharynx colonizer. In previous papers, the isolation and identification of the microorganisms of the normal microbiota of the respiratory tract of mice was reported by our research group. Also, the evolution from the moment they were born up to two months age was published . In the isolated microorganisms, the probiotic or beneficial characteristics were studied, selecting some strains of the genus Lactobacillus that shared some properties . From them, a strain of Lactobacillus fermentum was selected by the beneficial probiotic properties. Later the optimal dose to produce a transitory colonization or permanence [20, 21] and the protection exerted against S. pneumoniae  intranasally inoculated was determined.
The objective of the present paper was to study the effect of specific antimicrobial agents against the growth of S. pneumoniae and L. fermentum by "in vitro" assays. Also, to study the effect of Ampicillin, orally administered in a mice experimental model, against the intranasal inoculation of S. pneumoniae, L. fermentum or both microorganisms. The "in vivo" assays were complemented with histological and cytological studies to determine if there was some type of general response of the animals to the treatment.
Materials and methods
Microorganisms and culture media
L. fermentum was isolated from the respiratory tract (pharynx) of adult BALB/c mice [18, 20–22]. The mutants resistant to Rifampicin (RR) were obtained to differentiate the inoculated strains from the normal microbiota. The conditions of storage and culture were described previously [18, 20–22]. S. pneumoniae A6 serotype was isolated from human pneumonia-suffering subjects, and identified by standard techniques. The serotypification was performed at the "Servicio de Bacteriología Clínica, Instituto Nacional de Enfermedades Infecciosas-ANLIS "Dr Carlos G. Malbran, Buenos Aires, Argentina by Quellung technique. Pathogenicity in mice was increased by inoculating S. pneumoniae intraperitoneally . The pathogen was stored in 25% glycerol added to BHI broth (Brain-Heart Infusion) at -70°C.
those antibiotics broadly used for the treatment of Gram Positive microorganisms affecting the respiratory tract were studied by determining the Minimal Inhibitory Concentration: penicillin, ampicillin, ceftriazone, ceftazidine, claritromicine, tetracicline, rifampicin, ciprofloxacin, aztreonam, cloramphenicol and imipenen.
Quantitative determination of the bactericidal activity of antibiotics against lactobacilli
The Minimal Inhibitory Concentration Method (MIC) recommended by the National Committee for Clinical Laboratory Standards (NCCLS) was used, replacing the culture media by MRS agar as basal media , because Lactic acid bacteria are not able to grow in the recommended Muller Hinton agar. The reference strains used were Enterococcus faecalis ATCC 29212 and Staphylococcus aureus ATCC 29213.
Antibiotic sensitivity of S. pneumoniae. Method of diffusion and dilution in agar
The behavior of the pathogenic microorganisms with antimicrobial substances was determined by the qualitative and quantitative techniques of diffusion and dilution in agar (MIC), according to the National Committee for Clinical Laboratory Standards, 2001 (NCCLS). The antibiotics assayed for the qualitative method were oxacillin, vancomycin, chloramphenicol, tetracycline, rifampicin, ciprofloxacin, trimetroprim-sulphametoxazol, claritromycin. The antibiotics assayed for the quantitative method were penicillin, ampicillin, ceftriazone and claritromycin. The reference strain used was S. pneumoniae ATCC 49619.
"In vivo" assays
Each experimental group (or assay) included 24 to 30 animals. Four to six mice were killed in each experimental day. Each one of the "in vivo" experiments was performed twice, and their data used to calculate the media and Standard Deviation. The protocols used were accepted by the Animal Ethics committee of CERELA.
L. fermentum and Ampicillin assay
S. pneumoniae and Ampicillin assay
BALB/c mice were intranasally inoculated with a dose of 50 μl of a suspension of S. pneumoniae in saline solution (1 × 109 CFU/ml). The antibiotic was administered by the oral way in 4 doses of 100 mg/Kg/day, following the same scheme than before. The experimental protocol is schematized in Fig 1b.
L. fermentum + S. pneumoniae + Ampicilin assay
Mice were intranasally inoculated with RR L. fermentum (4 doses of 50 μl of a suspension of 1 × 109 CFU/ml), then challenged with S. pneumoniae A6 by the same way (50 μl of a suspension of 1 × 109 CFU/ml) and later treated with Ampicillin in four doses every 12 hours as before, as shown in Fig 1c.
All the experimental groups were sacrificed by cervical dislocation on days 2, 4, 7 and 10 post antibiotic administrations. The samples from nasopharynx and pharynx were obtained with a cotton swab. Trachea, bronchia and lung were aseptically removed and homogenized with a Teflon pestle. The number of microorganisms was determined by the successive dilutions method with peptone water, and plated in MRS agar-Rifampicin. The plates were incubated for 24 h. at 37°C in microaerophilic environment. The identification of microorganisms was performed by macroscopic, microscopic characteristics, Gram staining and biochemical tests.
the samples for histological assays were obtained from the higher trachea, located at the neck basis, bronchia in the area where the main bronchia are divided, and lung in the terminal bronchiole area and alveolar wall. They were fixed with 10% paraformaldehyde and stained with Hematoxylin-eosin and Ramon and Cajal technique . They were analyzed by light microscopy.
The left lobule of the lung was used to perform the cytological slices. The organ was first immersed in saline solution, then fixed in methanol for 3 min, and afterwards stained with the Romanovsky method (Giemsa stain-Merck,Germany) used routinely in the lab .
The numbers in the figures represent the mean and Standard Deviation of the results obtained in the two set of experiments performed for each assay. The Student's t test was applied to determine the differences statistically significant of the data.
The MIC results for L. fermentum (ug/ml) are as follows: penicillin, ampicilin, ceftriazone, ceftazidine, rifampicin, ciprofloxacin: ≥100 ug/ml, tetraciclin, imipenem and aztreonam: 10 ug/ml, cloramphenicol 1 ug/ml, claritromicine: 0.1 ug/ml. Comparing these values with those obtained for the MIC of Enterococcus spp and Streptococcus spp, type strains recommended by NCCLS, L. fermentum would be resistant to penicillin, ampicillin, ceftriazone, rifampicin and ciprofloxacin.
Sensitivity of S. pneumoniae to different antimicrobials by the disc diffusion assay
1.25 + 23.75
Sensitivity of S. pneumoniae to antimicrobials by the Agar dilution method (MIC)
MIC (ug/ml) Break point
"In vivo" assays
from the results obtained in "in vitro" sensitivity assays, that are predictive, the antibiotic Ampicillin was selected to be used in "in vivo" assays at the recommended dose for human beings (equivalent to the one applied to respiratory tract infections therapy).
Mice treated with L. fermentum (1 × 107 CFU/ml/dose) and Ampicillin
Mice challenged with S. pneumoniae (1 × 107 CFU/ml) and treated with Ampicillin
Mice treated with L. fermentum, S. pneumoniae and Ampicillin
Histological and cytological studies
Histological modifications of the respiratory tract of mice on day 4 of the experiment.
Without extension of the interalveolar wall
Alveolus and duct with plane epithelia.
Regular duct and alveolus. Alveolar light with macrophages
Regular exudation of mononuclear lymphocytes close to the interaveolar duct.
Slight areas with a scarce increased lymphocytic density
Cytology of lung impressions stained with Giemsa on day 4 post inoculation in mice treated with L. fermentum+S. pneumoniae+ampicillin
26 +/- 2
13 +/- 4
10 +/- 2
25 +/- 4
9 +/- 3
17 +/- 5
L. fermentum + ampicillin
14 +/- 4
30 +/- 5
28 +/- 4
14 +/- 3
9 +/- 2
5 +/- 4
S. pneumoniae +ampicillin
18 +/- 3
25 +/- 5
30 +/- 2
7 +/- 4
12 +/- 2
8 +/- 5
L.f + S.p . + ampicillin
20 +/- 2
30 +/- 2
25 +/- 3
13 +/- 2
6 +/- 2
6 +/- 3
One of the main goals of our research is to go further into the mechanisms involved in the probiotic effect in the respiratory tract [26, 27]. Having in mind that we have available a mice experimental model, our interest was focused in the knowledge of the effect produced by the antibiotics more frequently used to treat the respiratory infections on the kinetics of colonization of both microorganisms, either separately or combined. We were also interested in the effect produced by antibiotics on the microbial colonization by the potential use of probiotics together with antibiotics as therapeutic agents and for the restoration of the normal microbiota.
Our results showed that the administration of Ampicillin by the oral route and Lactobacilus intranasally increases their colonization in the respiratory tract. These results support the use of antibiotics together with probiotics, which would help in having a higher colonization of the protective microorganisms. A paper published by Dielemen et al  demonstrated that the administration of Lactobacillus GG prevents recurrence of colitis in transgenic rats after the treatment with Vancomycin and Imipenem, showing that our hypothesis has been proved in the intestinal tract.
Coincidently with these results, the treatment with Ampicillin, even though the S. pneumoniae strain used was sensitive to Ampicillin in the "in vitro" test, in the experiments performed in mice produces an increase in the number of the pathogenic microorganism that are also present a longer time in the tract. The pathogen produces a lymphocytic infiltration al the tracheal level, together with an increased inflammatory response evidenced in the lung cytological studies.
Why the response to the pathogen is different in "in vitro" assays than in "in vivo" experiments?. Referred to the behavior of Lactobacillus, there is a broad discussion based on the different results obtained through the application of "in vitro" test, and the differences found in "in vivo" assays. Even though the first one can be used as screening and to predict some characteristics or properties assayed in experimental animals models, one must consider that not always they are coincident .
In those experiments performed in mice treated with Lactobacillus, neumococci and Ampicillin, the final results is that the pathogen was cleared faster from the lung supporting the combined use of lactobacilli and antibiotics in the prevention of the infections produced by this pathogen. These results are also demonstrated by the histological slides, (Fig 5c) where the effect produced by the pneumococci decreased by the concomitant use of lactobacilli and antibiotics, when compared with the damage produced by the pathogen administration (Fig 5b). The histological modifications produced by the pathogen in mice previously protected with lactobacilli is lower compared to that obtained when the pathogen alone is inoculated into mice,  which produces congestion zones and edema in the terminal bronchiolar area.
The activation of lung or alveolar macrophages produced by the administration of L. fermentum, S. pneumoniae, or both, indicates the highly active non-specific branch of the immune system, which is an important first line of defense against microbial invasion in the lower airways infection. This activation could also help in the clearance of the neumococci observed on the 4th day of the experiments. These results do not agree with those from one infections produced by Pseudomonas aeruginosa, that does not produce an activation of the Pulmonary Alveolar Macrophages . The activation of the immune system at the respiratory tract is taking more relevance, mainly by some researchers who study this way of administration of different antigens and vaccines [15–17].
More studies must be undertaken trying to elucidate which are the mechanisms involved in the protection exerted by lactobacilli in the respiratory tract, and also which are the reasons of the increased colonization of the pathogen and lactobacilli by the effect of the Ampicillin treatment.
This paper was supported by CONICET (PIP 395) grants.
- Kertsz D, Di Fabio JL, De Cunto Brandileone MC, Castañeda E, Echáñiz-Aviles G, Heltmann I, Homma A, Hortal M, Lovgren M, Ruvinsky R, Talbot J, Weeks J, Spika JS, : Invasive Streptococcus pneumoniae infection in Latin American children. Results of the Pan American Health Organization Surveillance Study. Clin Infect Dis. 1998, 26: 1355-1361.View ArticleGoogle Scholar
- Pace J, Ruvinsky R, Reugeira M, Rossi A, S. pneumoniae working Group : Streptococcus pneumoniae: Surveillance in Argentinian children. Poster. International Symposium on Pneumococci and Pneumococcal Diseases, Helsingor. Denmark, Abstracts. 1998, 98-Google Scholar
- Ostroff SM, Hamison LH, Khallaf N, Assad MT, Guirguis NI, Hamington S, Alamy : Resistance patterns of Streptococcus pneumoniae and Haemophilus influenzae isolates recovered in Egypt from children with pneumoniae. The Antimicrobial Resistance Surveillance. Clin. Infect Dis. 1996, 23: 1069-1074.View ArticlePubMedGoogle Scholar
- Rossi A, Ruvinsky R, Regueira M, Corso A, Pace J, Gentile A, Di Fabio JL: S. pneumoniae working Group. Distribution of Capsular Types and Penicillin-Resistance of Strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years old. Microbiol Drug Resist. 1997, 3: 135-139.View ArticleGoogle Scholar
- Appelbaum PC: Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infetc Dis. 2002, 15: 1613-1620. 10.1086/340400.View ArticleGoogle Scholar
- Deeks S, Palacio R, Ruvinsky R, Kertesz D, Hotal M, Rossi A, Spika JS, Di Fabio JL: The Streptococcus pneumoniae working Group. Risk factors and course of illness among children with invasive penicilin-resistant Streptococcus pneumoniae. Pedit. 1999, 103: 410-413.Google Scholar
- Charteris XE, Kelly PM, Morelli L, Collins JK: Antibiotics susceptibility of potentially probiotic Lactobacillus species. J Food Prot. 1998, 61: 1636-1643.PubMedGoogle Scholar
- Charteris WC, Kelly PM, Morelli L, Collins K: Gradient Diffusion Antibiotic Susceptibility testing of potentially probiotic Lactobacilli. J Food Prot. 2001, 64: 2007-2014.PubMedGoogle Scholar
- Danielsen M, Wind A: Susceptibility of Lactobacillus spp. to antimicrobial agents. Int J Food Microbiol. 2003, 15: 1-11. 10.1016/S0168-1605(02)00254-4.View ArticleGoogle Scholar
- Svensson JMR, Faclam R, Thornsberry C: Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus and Lactobacillus species. Antimic Ag and Chemoth. 1990, 543-549.Google Scholar
- De Vrese M, Schrezenmeir J: Probiotic and non intestinal infections conditions. Brit J Nutr. 2002, 88 (S1): S59-66. 10.1079/BJN2002630.View ArticlePubMedGoogle Scholar
- Havenaar R, Ten Brick H, Huis in't Veld JH: Chap 9. Selection of strains for probiotic use. in: Probiotics: the scientific Basis. Edited by: Fuller R. 1992, 209-Chapmman and Hall. LondonView ArticleGoogle Scholar
- Huis in't Veld JHJ, Stortt C: Selection criteria for probiotic microorganisms. in: Gut flora and health-past, present and future. Edited by: Leedrs AR, Rowland IR. 1996, 27-36. The Royal Society of Medicine Press Ltd. LondonGoogle Scholar
- Reid G: The scientific basis for probiotic strains of lactobacillus. Appl Environ Microbiol. 1999, 65 (9): 3763-6.PubMed CentralPubMedGoogle Scholar
- Bermudez-Humaran LH, Langella P, Cortez-Perez N, Gruss A, Tamez-Guerra RS, Oliveira SC, Sauceda-Cardenas O, Montes de Oca-Luna R, Le Loir Y: Intranasal administration of recombinant Lactococcus lactis secreting murine interleukine-12 enhances antigen-specific Th1 cytokine production. Infect Immun. 2003, 71: 1887-1896. 10.1128/IAI.71.4.1887-1896.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Bermúdez-Humaran LH, Langella P, Cortes-Perez NG, Gruss A, Montes de Oca-Luna R, Le Loir Y: Immunisation intranasale chez la souris avec des lactocoques recombinants exportant l'interleukine-12 murine et l'antigene E7 du Papillomavirus humain. Le Lait. 2004, 84: 191-206. 10.1051/lait:2003048.View ArticleGoogle Scholar
- Cortez-Perez N, Bermudez-Humaran LH, Le Loir Y, Rodriguez-Padilla C, Gruss A, Langella P, Montes de Oca-Luna R: Mice immunization by intranasal administration of a Lactococcus lactis strain displaying a cell-wall anchored HPV16-E7 protein. FEMS Microbiol Lett. 2004, 229: 37-42. 10.1016/S0378-1097(03)00778-X.View ArticleGoogle Scholar
- Cangemi de Gutierrez R, Nader O, Ruiz Holgado A, Nader-Macias ME: Microbial flora variations in the respiratory tract of mice. Mem Osv Cruz Brasil. 1999, 94: 701-707.View ArticleGoogle Scholar
- Cangemi de Gutierrez R, Nader-Macías ME: Screening of probiotics characteristics of strains from the respiratory tract of mice. 2004Google Scholar
- Cangemi de Gutierrez RC, Santos de Araoz VS, Nader-Macias ME: Effect of intranasal administration of Lactobacillus fermentum on the respiratory tract of mice. Biol Pharm Bull. 2000, 23: 973-978.View ArticlePubMedGoogle Scholar
- Santos V, Cangemi R, Winik B, Nader-Macías ME: Ultraestructural studies on the respiratory tract of mice inoculated intranasally with L. fermentum. Biocell. 2001, 25: 121-129.PubMedGoogle Scholar
- Cangemi R, Santos V, Nader-Macías ME: Protective effect of intranasally inoculated L. fermentum against S. pneumoniae challenge on the mouse respiratory tract. FEMS Inmun and Med Microbiol. 2001, 1341: 1-9.Google Scholar
- De Man JC, Rogosa M, Sharpe ME: A medium for the cultivation of lactobacilli. J Appl Bact. 1960, 23: 30-35.Google Scholar
- Gaytan F, Morales C, Bellido C, Aguilar E, Sanches-Criado JE: Ovarian Follicle Macrophages: Is Follicular Atresia in the Immature Rat a Macrophage-Mediated Event?. Biol Reprod. 1998, 58: 52-59.View ArticlePubMedGoogle Scholar
- Grignaschi V, Diaz N, Alonso M, Lardo M, Lucero G: Citomorfología y Citoquímica Hemáticas. 1983, Edit Britania. ArgentinaGoogle Scholar
- Lidbeck AJ, Gustafsson CE: Impact of Lactobacillus acidophillus supplements on the human oropharyngeal and intestinal microflora. Scand J Inf Dis. 1998, 1: 531-537.Google Scholar
- Tannock G: Probiotics: a critical Review. 1999, Horizons Scientific Press (Eds) LondonGoogle Scholar
- Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB: Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 2003, 52: 370-376. 10.1136/gut.52.3.370PubMed CentralView ArticlePubMedGoogle Scholar
- Morelli L: In vitro selection of probiotic lactobacilli: a critical appraisal. Curr Issues Intest Microbiol. 2000, 1: 59-67.PubMedGoogle Scholar
- Cheung DOY, Halsey K, Speert DP: Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Inf and Imm. 2000, 68: 4585-4592. 10.1128/IAI.68.8.4585-4592.2000.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.